Alignment Healthcare, Inc. (NASDAQ:ALHC - Get Free Report) President Dawn Christine Maroney sold 30,000 shares of the business's stock in a transaction that occurred on Monday, March 16th. The stock was sold at an average price of $17.48, for a total value of $524,400.00. Following the transaction, the president directly owned 1,095,562 shares in the company, valued at $19,150,423.76. The trade was a 2.67% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.
Dawn Christine Maroney also recently made the following trade(s):
- On Thursday, March 12th, Dawn Christine Maroney sold 29,113 shares of Alignment Healthcare stock. The shares were sold at an average price of $17.45, for a total value of $508,021.85.
- On Tuesday, February 17th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The stock was sold at an average price of $20.63, for a total transaction of $618,900.00.
- On Thursday, January 15th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The shares were sold at an average price of $22.48, for a total transaction of $674,400.00.
- On Tuesday, January 6th, Dawn Christine Maroney sold 228,152 shares of Alignment Healthcare stock. The shares were sold at an average price of $21.33, for a total transaction of $4,866,482.16.
- On Friday, January 2nd, Dawn Christine Maroney sold 100,000 shares of Alignment Healthcare stock. The stock was sold at an average price of $20.03, for a total value of $2,003,000.00.
- On Monday, December 29th, Dawn Christine Maroney sold 282,070 shares of Alignment Healthcare stock. The stock was sold at an average price of $18.74, for a total value of $5,285,991.80.
Alignment Healthcare Price Performance
Shares of Alignment Healthcare stock opened at $17.92 on Wednesday. The company has a quick ratio of 1.71, a current ratio of 1.71 and a debt-to-equity ratio of 1.80. Alignment Healthcare, Inc. has a twelve month low of $11.63 and a twelve month high of $23.87. The company has a 50-day simple moving average of $20.62 and a two-hundred day simple moving average of $18.79. The stock has a market capitalization of $3.66 billion, a price-to-earnings ratio of -1,790.21, a price-to-earnings-growth ratio of 2.56 and a beta of 1.18.
Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last issued its quarterly earnings results on Thursday, February 26th. The company reported ($0.05) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.15) by $0.10. The business had revenue of $1.01 billion during the quarter, compared to analysts' expectations of $1 billion. Alignment Healthcare had a negative return on equity of 0.49% and a negative net margin of 0.02%.The firm's revenue for the quarter was up 44.4% compared to the same quarter last year. During the same period in the previous year, the company posted ($0.16) earnings per share. Analysts forecast that Alignment Healthcare, Inc. will post -0.69 EPS for the current year.
Analysts Set New Price Targets
A number of brokerages have issued reports on ALHC. UBS Group increased their price objective on shares of Alignment Healthcare from $18.00 to $21.00 and gave the stock a "neutral" rating in a research note on Wednesday, January 14th. Weiss Ratings restated a "sell (d-)" rating on shares of Alignment Healthcare in a research report on Wednesday, January 21st. Piper Sandler upped their price target on shares of Alignment Healthcare from $20.00 to $30.00 and gave the stock an "overweight" rating in a report on Tuesday, January 6th. Wall Street Zen lowered shares of Alignment Healthcare from a "buy" rating to a "hold" rating in a research report on Saturday, March 7th. Finally, JPMorgan Chase & Co. boosted their price objective on shares of Alignment Healthcare from $23.00 to $26.00 and gave the company an "overweight" rating in a research report on Thursday, February 5th. One equities research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, Alignment Healthcare presently has an average rating of "Moderate Buy" and an average target price of $24.56.
Get Our Latest Stock Report on Alignment Healthcare
Institutional Inflows and Outflows
Institutional investors have recently bought and sold shares of the business. Allworth Financial LP boosted its stake in shares of Alignment Healthcare by 8.9% in the 4th quarter. Allworth Financial LP now owns 6,917 shares of the company's stock valued at $137,000 after purchasing an additional 566 shares in the last quarter. State of Alaska Department of Revenue grew its holdings in shares of Alignment Healthcare by 6.0% during the 4th quarter. State of Alaska Department of Revenue now owns 11,296 shares of the company's stock valued at $223,000 after purchasing an additional 636 shares during the last quarter. Integrated Wealth Concepts LLC increased its position in Alignment Healthcare by 6.3% during the 3rd quarter. Integrated Wealth Concepts LLC now owns 11,230 shares of the company's stock worth $196,000 after purchasing an additional 665 shares in the last quarter. Parallel Advisors LLC increased its position in Alignment Healthcare by 87.7% during the 4th quarter. Parallel Advisors LLC now owns 1,654 shares of the company's stock worth $33,000 after purchasing an additional 773 shares in the last quarter. Finally, Universal Beteiligungs und Servicegesellschaft mbH lifted its stake in Alignment Healthcare by 2.3% in the 3rd quarter. Universal Beteiligungs und Servicegesellschaft mbH now owns 37,752 shares of the company's stock valued at $659,000 after purchasing an additional 844 shares during the last quarter. Institutional investors and hedge funds own 86.19% of the company's stock.
About Alignment Healthcare
(
Get Free Report)
Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.
At the core of Alignment Healthcare's approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
